Provided by Tiger Fintech (Singapore) Pte. Ltd.

Edwards Lifesciences

72.78
+1.401.96%
Volume:1.69M
Turnover:121.95M
Market Cap:42.79B
PE:10.44
High:72.91
Open:71.25
Low:70.95
Close:71.38
Loading ...

Edwards Lifesciences Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.
·
Yesterday

Nyse Order Imbalance 572449.0 Shares on Sell Side

THOMSON REUTERS
·
Yesterday

Shield AI and L3Harris Team for Breakthrough in Autonomy

PR Newswire
·
27 Feb

Edwards Lifesciences Corp. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
26 Feb

Edwards Lifesciences to Present at the TD Cowen 45th Annual Health Care Conference

Business Wire
·
25 Feb

Edwards Lifesciences Corp. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
20 Feb

Top Research Reports for Meta Platforms, BlackRock & Palo Alto

Zacks
·
20 Feb

AV Unveils JUMP 20-X: Revolutionizing Autonomous Maritime Operations with Unmatched Precision and Versatility

Business Wire
·
17 Feb

The three-year loss for Edwards Lifesciences (NYSE:EW) shareholders likely driven by its shrinking earnings

Simply Wall St.
·
16 Feb

Edwards Lifesciences: Strong Performance Amid Modest Future Growth Expectations and Operational Challenges

TIPRANKS
·
15 Feb

Edwards Lifesciences Director Makes a Significant Stock Sale!

TIPRANKS
·
15 Feb

Director Cashes In on Edwards Lifesciences Stock in Major Sale

TIPRANKS
·
14 Feb

Edwards Lifesciences Is Maintained at Overweight by Barclays

Dow Jones
·
13 Feb

Edwards Lifesciences: Promising Growth with Strong Performance in TMTT and TAVR Segments Justifies Buy Rating

TIPRANKS
·
13 Feb

Edwards Lifesciences price target raised to $71 from $66 at Canaccord

TIPRANKS
·
13 Feb

Edwards Lifesciences Corp : Canaccord Genuity Raises Target Price to $71 From $68

THOMSON REUTERS
·
13 Feb